Literature DB >> 33653967

Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites.

Claudia Grajeda-Iglesias1,2,3, Sylvère Durand1,2,3, Romain Daillère4, Kristina Iribarren1,5,6,7, Fabien Lemaitre1,5,6,7, Lisa Derosa1,5,6,7, Fanny Aprahamian1,2,3, Noélie Bossut1,2,3, Nitharsshini Nirmalathasan1,2,3, Frank Madeo8,9,10, Laurence Zitvogel1,5,6,7, Guido Kroemer1,2,3,11,12,13.   

Abstract

The presence of Akkermansia muciniphila (Akk) in the human gut is associated with good health, leanness and fitness. Mouse experimentation has demonstrated positive effects for Akk, which counteracts aging, mediates antiobesity and antidiabetic effects, dampens inflammation and improves anticancer immunosurveillance. Clinical trials have confirmed antidiabetic effects for Akk. Here, we investigated the time-dependent effects of oral administration of Akk (which was live or pasteurized) and other bacteria to mice on the metabolome of the ileum, colon, liver and blood plasma. Metabolomics was performed by a combination of chromatographic and mass spectrometric methods, yielding a total of 1.637.227 measurements. Akk had major effects on metabolism, causing an increase in spermidine and other polyamines in the gut and in the liver. Pasteurized Akk (Akk-past) was more efficient than live Akk in elevating the intestinal concentrations of polyamines, short-chain fatty acids, 2-hydroxybutyrate, as well multiple bile acids, which also increased in the circulation. All these metabolites have previously been associated with human health, providing a biochemical basis for the beneficial effects of Akk.

Entities:  

Keywords:  Akkermansia muciniphila; fecal microbial transplantation; metabolomics; microbiota; polyamines

Mesh:

Substances:

Year:  2021        PMID: 33653967      PMCID: PMC7993698          DOI: 10.18632/aging.202739

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  57 in total

Review 1.  Autophagy in hepatic adaptation to stress.

Authors:  Younis Hazari; José Manuel Bravo-San Pedro; Claudio Hetz; Lorenzo Galluzzi; Guido Kroemer
Journal:  J Hepatol       Date:  2020-01       Impact factor: 25.083

Review 2.  Anticancer effects of the microbiome and its products.

Authors:  Laurence Zitvogel; Romain Daillère; María Paula Roberti; Bertrand Routy; Guido Kroemer
Journal:  Nat Rev Microbiol       Date:  2017-05-22       Impact factor: 60.633

3.  Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Authors:  Romain Daillère; Marie Vétizou; Nadine Waldschmitt; Takahiro Yamazaki; Christophe Isnard; Vichnou Poirier-Colame; Connie P M Duong; Caroline Flament; Patricia Lepage; Maria Paula Roberti; Bertrand Routy; Nicolas Jacquelot; Lionel Apetoh; Sonia Becharef; Sylvie Rusakiewicz; Philippe Langella; Harry Sokol; Guido Kroemer; David Enot; Antoine Roux; Alexander Eggermont; Eric Tartour; Ludger Johannes; Paul-Louis Woerther; Elisabeth Chachaty; Jean-Charles Soria; Encouse Golden; Silvia Formenti; Magdalena Plebanski; Mutsa Madondo; Philip Rosenstiel; Didier Raoult; Vincent Cattoir; Ivo Gomperts Boneca; Mathias Chamaillard; Laurence Zitvogel
Journal:  Immunity       Date:  2016-10-04       Impact factor: 31.745

4.  Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice.

Authors:  Clea Bárcena; Rafael Valdés-Mas; Pablo Mayoral; Cecilia Garabaya; Sylvère Durand; Francisco Rodríguez; María Teresa Fernández-García; Nuria Salazar; Alicja M Nogacka; Nuria Garatachea; Noélie Bossut; Fanny Aprahamian; Alejandro Lucia; Guido Kroemer; José M P Freije; Pedro M Quirós; Carlos López-Otín
Journal:  Nat Med       Date:  2019-07-22       Impact factor: 53.440

5.  Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice.

Authors:  Ryoko Kibe; Shin Kurihara; Yumi Sakai; Hideyuki Suzuki; Takushi Ooga; Emiko Sawaki; Koji Muramatsu; Atsuo Nakamura; Ayano Yamashita; Yusuke Kitada; Masaki Kakeyama; Yoshimi Benno; Mitsuharu Matsumoto
Journal:  Sci Rep       Date:  2014-04-01       Impact factor: 4.379

6.  Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Authors:  Clara Depommier; Amandine Everard; Céline Druart; Hubert Plovier; Matthias Van Hul; Sara Vieira-Silva; Gwen Falony; Jeroen Raes; Dominique Maiter; Nathalie M Delzenne; Marie de Barsy; Audrey Loumaye; Michel P Hermans; Jean-Paul Thissen; Willem M de Vos; Patrice D Cani
Journal:  Nat Med       Date:  2019-07-01       Impact factor: 53.440

7.  A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice.

Authors:  Sarah Lévesque; Julie Le Naour; Federico Pietrocola; Juliette Paillet; Margerie Kremer; Francesca Castoldi; Elisa E Baracco; Yan Wang; Erika Vacchelli; Gautier Stoll; Ariane Jolly; Pierre De La Grange; Laurence Zitvogel; Guido Kroemer; Jonathan G Pol
Journal:  Oncoimmunology       Date:  2019-09-07       Impact factor: 8.110

Review 8.  The gut microbiota at the intersection of diet and human health.

Authors:  Christopher L Gentile; Tiffany L Weir
Journal:  Science       Date:  2018-11-16       Impact factor: 47.728

9.  Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice.

Authors:  Lingyan Ma; Yinhua Ni; Zhe Wang; Wenqing Tu; Liyang Ni; Fen Zhuge; Aqian Zheng; Luting Hu; Yufeng Zhao; Liujie Zheng; Zhengwei Fu
Journal:  Gut Microbes       Date:  2020-11-09

10.  The gut microbiota is associated with immune cell dynamics in humans.

Authors:  Jonas Schluter; Jonathan U Peled; Bradford P Taylor; Kate A Markey; Melody Smith; Ying Taur; Rene Niehus; Anna Staffas; Anqi Dai; Emily Fontana; Luigi A Amoretti; Roberta J Wright; Sejal Morjaria; Maly Fenelus; Melissa S Pessin; Nelson J Chao; Meagan Lew; Lauren Bohannon; Amy Bush; Anthony D Sung; Tobias M Hohl; Miguel-Angel Perales; Marcel R M van den Brink; Joao B Xavier
Journal:  Nature       Date:  2020-11-25       Impact factor: 69.504

View more
  24 in total

Review 1.  Bladder cancer, inflammageing and microbiomes.

Authors:  Austin Martin; Benjamin L Woolbright; Shahid Umar; Molly A Ingersoll; John A Taylor
Journal:  Nat Rev Urol       Date:  2022-07-07       Impact factor: 16.430

Review 2.  Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms.

Authors:  Patrice D Cani; Clara Depommier; Muriel Derrien; Amandine Everard; Willem M de Vos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-31       Impact factor: 73.082

Review 3.  Targeting the gut and tumor microbiota in cancer.

Authors:  Elizabeth M Park; Manoj Chelvanambi; Neal Bhutiani; Guido Kroemer; Laurence Zitvogel; Jennifer A Wargo
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

Review 4.  Challenges in the production and use of probiotics as therapeuticals in cancer treatment or prevention.

Authors:  Alejandra Mejía-Caballero; Vianey Anahi Salas-Villagrán; Alaide Jiménez-Serna; Amelia Farrés
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

Review 5.  The ups and downs of caloric restriction and fasting: from molecular effects to clinical application.

Authors:  Sebastian J Hofer; Didac Carmona-Gutierrez; Melanie I Mueller; Frank Madeo
Journal:  EMBO Mol Med       Date:  2021-11-15       Impact factor: 12.137

6.  Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome.

Authors:  Clara Depommier; Amandine Everard; Céline Druart; Dominique Maiter; Jean-Paul Thissen; Audrey Loumaye; Michel P Hermans; Nathalie M Delzenne; Willem M de Vos; Patrice D Cani
Journal:  Gut Microbes       Date:  2021 Jan-Dec

7.  Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032).

Authors:  Stéphane Isnard; Brandon Fombuena; Jing Ouyang; Léna Royston; John Lin; Simeng Bu; Nancy Sheehan; Peter L Lakatos; Talat Bessissow; Nicolas Chomont; Marina Klein; Bertrand Lebouché; Cecilia T Costiniuk; Bertrand Routy; André Marette; Jean-Pierre Routy
Journal:  BMJ Open       Date:  2022-01-17       Impact factor: 2.692

8.  Alteration of Gut Microbiota Relates to Metabolic Disorders in Primary Aldosteronism Patients.

Authors:  Yu Liu; Qingyao Jiang; Zhihong Liu; Sikui Shen; Jianzhong Ai; Yuchun Zhu; Liang Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-17       Impact factor: 5.555

Review 9.  Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer.

Authors:  Julie Veziant; Romain Villéger; Nicolas Barnich; Mathilde Bonnet
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

Review 10.  Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.

Authors:  Haokun Shen; Zitong Zhao; Zengjue Zhao; Yuyi Chen; Linghua Zhang
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.